Seeking GP feedback on Clinical & Referral Pathways

October 9, 2024

We need to understand more about your views, expectations and experiences regarding Clinical and Referral Pathways platforms. 

Following consultations in 2022, and a feasibility study in 2023, the National PHN Cooperative is seeking to learn more about GP user needs and expectations of a clinical assessment and referral pathways platform, both currently and into the future.

The project proposes to identify areas of improvement with the existing offering to deliver better patient care within general practice. 

The PHN collaborative has partnered with The Behaviour Change Collaborative to conduct this research, which will be carried out in two phases to gather valuable insights from general practitioners. 

Phase one will involve paid one-on-one interviews and focus groups with our market research partner, to help gain deeper insights into GP's individual experiences, attitudes and expectations as they relate to the existing system and any potential future solutions. GPs can opt-in to these interviews by completing the short screening questions linked below. All participants will be paid for their time.

Phase two involves a more detailed, quantitative survey of GPs, to collect responses from a diverse range of geographies, demographics and user profiles across all PHNs in Australia. Participation is crucial to ensure that the perspectives of those working within our PHN are suitably represented. Of most interest is feedback from GPs who are not currently involved in the maintenance and development of an existing solution.

The Expression of Interest to participate is open until COB on Wednesday 16 October.

Click here to express your interest

Latest news

February 21, 2025
Activity 2 of the Chronic Condition Management (CCM) Activation Series will focus on planning with your practice team to ensure they aware and prepared for the upcoming changes.
February 19, 2025
Melbourne University is inviting General Practices to participate in the ReadytoScreen randomised control trial, an important initiative to support the implementation of lung cancer screening in your community.
February 5, 2025
A new way to support people with increased vulnerabilities and complex health needs.
Share by: